NCT01772303View on ClinicalTrials.gov

Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

December 31, 2013

Conditions
Hard to Heal Wounds
Interventions
DRUG

HO/03/03 10-40 µg

HO/03/03 10-40µg once daily (Topically) for up to 24 weeks.

Trial Locations (1)

Unknown

RECRUITING

Maccabi Health Services, Wound Clinic, Haifa

Sponsors

Lead Sponsor

HealOr
All Listed Sponsors
lead

HealOr

INDUSTRY